Pharma Marketing NewsThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

45 records returned

Risk Mitigation and Its Impact on Pharma MarketingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes ParagonRx's ideas about how to develop a REMS that can be a win-win-win situation for you, your product, and the patient. (Source: Pharma Marketing News)
Source: Pharma Marketing News - October 29, 2009 Category: Pharmaceuticals Source Type: info

Fear and Loathing in Washington, DCEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
John Mack, Editor of Pharma Marketing News, will make a presentation in front of the DDMAC at the November, 2009, public hearing on Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools. (Source: Pharma Marketing News)
Source: Pharma Marketing News - October 29, 2009 Category: Pharmaceuticals Source Type: info

Pharmaceutical Market Access 2010Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article addresses that question. (Source: Pharma Marketing News)
Source: Pharma Marketing News - October 29, 2009 Category: Pharmaceuticals Source Type: info

Social Media Adverse Event Reporting Safe HarborsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article presents ideas for regulatory 'safe harbors' under which pharmaceutical companies would be relieved of the responsibility of monitoring social media for adverse events. Includes a detailed summary of responses to the survey "FDA Regulation of Drug & Device Promotion via the Internet & Social Media" regarding social media adverse event monitoring, processing, challenges, and uncertainties. (Source: Pharma Marketing News)
Source: Pharma Marketing News - October 29, 2009 Category: Pharmaceuticals Source Type: info

Pharmaguy's Twitter FollowersEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes the findings of a survey of over 400 of @pharmaguy's followers. The results will give you a better idea why people who are interested in the pharmaceutical industry use Twitter and what they expect to get out of it. (Source: Pharma Marketing News)
Source: Pharma Marketing News - September 22, 2009 Category: Pharmaceuticals Source Type: info

Let's Respond to FDA's Questions Regarding Its Regulation of Social MediaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The FDA is requesting the public to submit comments to a series of specific questions regarding the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools. These questions are included in a new survey created by Pharma Marketing News. Let's use this survey to help educate the FDA on the issues. (Source: Pharma Marketing News)
Source: Pharma Marketing News - September 22, 2009 Category: Pharmaceuticals Source Type: info

Pharma-Sponsored Medical GhostwritingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
What the Ghosts Have to Say About It Pharma Marketing News surveyed readers to determine if medical journal articles sponsored and ghostwritten by drug companies are a legitimate part of marketing to physicians and to get opinions on various other issues raised in the press about ghostwriting. (Source: Pharma Marketing News)
Source: Pharma Marketing News - September 22, 2009 Category: Pharmaceuticals Source Type: info

What If There Were No Rules in Pharma Marketing?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Be Sure Not to Cut Off the Ends of Your Ham What If There Were No Rules in Pharma Marketing? There's no FDA, no DDMAC, no FTC. Your company guidelines and rules don't exist and your regulatory and legal teams have been disbanded. It's a free-for-all and there are no rules. The question is: what would you do? (Source: Pharma Marketing News)
Source: Pharma Marketing News - September 22, 2009 Category: Pharmaceuticals Source Type: info

Waning Pharma Support of CMEEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summaries Congressional testimony, ACCME data, and results of a reader survey on this topic. (Source: Pharma Marketing News)
Source: Pharma Marketing News - August 6, 2009 Category: Pharmaceuticals Source Type: info

Social Media & the Truncated News PyramidEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PR people are used to issuing press releases to a few journalists at the top of the traditional news pyramid. When the top was blown off by the social media revolution, these professionals had no proven mechanism by which to reach the many thousands of bloggers at the BOTTOM of the pyramid -- until now. (Source: Pharma Marketing News)
Source: Pharma Marketing News - August 6, 2009 Category: Pharmaceuticals Source Type: info

Social Communications in HealthcareEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article provides several summaries written by the roundtable discussion leaders themselves. (Source: Pharma Marketing News)
Source: Pharma Marketing News - August 6, 2009 Category: Pharmaceuticals Source Type: info

Owning the Prescription PadEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article presents such a model developed by TNS Healthcare, A Kantar Health Company. (Source: Pharma Marketing News)
Source: Pharma Marketing News - August 6, 2009 Category: Pharmaceuticals Source Type: info

Whither Twitter for Pharma?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Twitter is growing by leaps and bounds! Which makes Twitter attractive to pharmaceutical marketers. But can pharma's Twitter campaigns reach a significant number of people? Will they reach the right people? Is Twitter even appropriate for branded messages? (Source: Pharma Marketing News)
Source: Pharma Marketing News - July 9, 2009 Category: Pharmaceuticals Source Type: info

FDA Draft Guidance on Risk CommunicationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The recent FDA Draft Guidance for Industry, Presenting Risk Information in Prescription Drug and Medical Device Promotion guidance focuses almost exclusively on print and broadcast promotional ads. It is possible, however, to apply some of FDA's "thinking" to certain kinds of Internet ads such as search engine paid ads. (Source: Pharma Marketing News)
Source: Pharma Marketing News - July 9, 2009 Category: Pharmaceuticals Source Type: info

How Should Pharma Engage in Social Networks?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes the results of that survey. (Source: Pharma Marketing News)
Source: Pharma Marketing News - July 9, 2009 Category: Pharmaceuticals Source Type: info

Pharma Marketers Dive Deeper Into Social MediaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article focuses in some detail on three interesting pharma social media initiatives: (1) Procter & Gamble's Asacol Community for Ulcerative Colitis Patients; (2) Novo Nordisk's Levemir-branded Race With Insulin Twitter account; and (3) UCB's sponsored epilepsy community on the PatientsLikeMe website. (Source: Pharma Marketing News)
Source: Pharma Marketing News - July 9, 2009 Category: Pharmaceuticals Source Type: info

Report from the Social Pharmer "Unconference"Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes key presentations made at the April 21, 2009, Social Pharmer 'unconference' where leading pahram social media proponents presnted ideas on how the industry can overcome the barriers. (Source: Pharma Marketing News)
Source: Pharma Marketing News - April 30, 2009 Category: Pharmaceuticals Source Type: info

Social Media: Opportunity or Nightmare?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The April 2009 issue of Pharma Marketing News is focused on social media, patient empowerment (which is powered by social media), and the constraints of regulation. This OpEd presents some background on social media usage and discusses how the articles in this issue are related. (Source: Pharma Marketing News)
Source: Pharma Marketing News - April 30, 2009 Category: Pharmaceuticals Source Type: info

Socially Challenged PharmaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes the recent Digital Pharma Europe congress where it was the time right to see that European pharma marketers are also interested in new/social/digital media in pharma, but may be more constrained by regulators than their brethern in the US. (Source: Pharma Marketing News)
Source: Pharma Marketing News - April 30, 2009 Category: Pharmaceuticals Source Type: info

The Empowered PatientEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article presents a case for the drug industry to adopt a patient-centric model in which pharma companies can develop unique expertise in decoding the behavior, needs, motivations of empowered patients and then use this knowledge as the basis for helping healthcare professionals and payers to put into place programs that achieve better patient outcomes. (Source: Pharma Marketing News)
Source: Pharma Marketing News - April 30, 2009 Category: Pharmaceuticals Source Type: info

Developing Guidelines for Pharma's Use of the Internet & Social MediaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A Call for a Public Hearing at FDA Shouldn't we make sure that when it comes time for the FDA to actually create a guidance document on social media that it does it with input from ALL stakeholders? Survey results. (Source: Pharma Marketing News)
Source: Pharma Marketing News - April 30, 2009 Category: Pharmaceuticals Source Type: info

New Privacy Rules in Economic Stimulus LawEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article reviews the medical privacy restrictions included in the American Recovery and Reinvestment Act, which President Obama signed into law on Feb. 17, 2009, and discusses the impact these restrictions might have on pharmaceutical marketing. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 30, 2009 Category: Pharmaceuticals Source Type: info

Syndication is da Bomb!Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Many publishers, including Pharma Marketing News, and even the FDA syndicate content via RSS feeds. In this UpFront piece, John Mack, Pharma Marketing News Editor, reviews how PMN uses RSS feeds to provide content to our readers from a wide variety of sources including the FDA, PhRMA, major news media, blogs, trade publications, etc. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 30, 2009 Category: Pharmaceuticals Source Type: info

FDA's Use of Social MediaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article describes FDA's social networking initiatives in context of these questions. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 30, 2009 Category: Pharmaceuticals Source Type: info

Will Healthcare be Rationed or Rational?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In this article, Kim Slocum, former Director, Strategic Planning & Business Development at AstraZeneca describes several alternative future health care system scenarios and makes a case for the industry to support Comparative Effectiveness Research or CER. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 30, 2009 Category: Pharmaceuticals Source Type: info

Pharma's Bad Rep or Bad RapEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes the results of the "How to Earn Back the Public's Trust" survey hosted by Pharma Marketing News between February 4, 2009 and March 14, 2009 , including selected comments from respondents and other commentators. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 30, 2009 Category: Pharmaceuticals Source Type: info

Sales Force Effectiveness MetricsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes a recent discussion between eyeforpharma's Editor Lisa Roner and Hans Nagl, Promotion Response Modelling Manager, Shire, about how the current economy and changing pharma landscape is impacting program effectiveness measures. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 3, 2009 Category: Pharmaceuticals Source Type: info

Pledge to Subscribers & AdvertisersEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pharma Marketing News and the entire Pharma Marketing Network comprised of Web sites, blogs and social networking discussion boards pledges to help its readers, subscribers and advertisers do well during this tough time for the economy. Lower prices, less advertising, more free exposure, and different channels of communication are some of the changes we plan to implement. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 3, 2009 Category: Pharmaceuticals Source Type: info

The New Rules of Marketing & PREmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Book Review and Insights for Pharma The pharmaceutical industry must find ways to utilize the new media tools that other industries use while ensuring compliance with FDA regulations. The good news is we can! The author summaries the content of the book and offers practical guidelines for the pharma marketers. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 3, 2009 Category: Pharmaceuticals Source Type: info

Building the Optimal Service ModelEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article presents a summary of a recent TNS Healthcare webinar and personal conversations with presenters conducted beforehand. Included are NEW research results about how US and European physicians rate pharmaceutical companies against a number of customer value points that are important in achieving success with the new sales model. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 3, 2009 Category: Pharmaceuticals Source Type: info

The View From ePharma SummitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article is a compilation of summaries of presentations made at the 2009 ePharma Summit. Included are highlights posted to the ePharma Summit and other blogs during the conference and insights on epharma marketing issues provided by several conference speakers and attendees. (Source: Pharma Marketing News)
Source: Pharma Marketing News - March 3, 2009 Category: Pharmaceuticals Source Type: info

The Hypocrisy of Healthcare Marketing RestrictionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Stand Up for Healthcare Marketing Free Speech! So says Dmitriy Kruglyak of Trusted.MD Network who thinks PhRMA has caved in to hypocritical attacks by the media and other critics of the industry. (Source: Pharma Marketing News)
Source: Pharma Marketing News - January 28, 2009 Category: Pharmaceuticals Source Type: info

Is There Life After Pharma?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Before the year is out you probably will know one or two or more people who are no longer employed in this industry. These people may have several employment options, but they may no longer be sought after by any company related to the drug industry. So, what is life like after pharma? (Source: Pharma Marketing News)
Source: Pharma Marketing News - January 28, 2009 Category: Pharmaceuticals Source Type: info

FDA Finalizes Guidance on Distribution of ReprintsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article outlines the major provisions of the guidance and helps you learn how to make iy work for your company. (Source: Pharma Marketing News)
Source: Pharma Marketing News - January 28, 2009 Category: Pharmaceuticals Source Type: info

The ePharma Pioneer Club™Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Convincing Pharma Marketers to Engage in "e" An EXCLUSIVE, members-only Facebook Group through which pharmaceutical eMarketing experts 'meet' to discuss and exchange views on how to advance the use of the Internet and other technologies in pharmaceutical marketing, sales, and communications. (Source: Pharma Marketing News)
Source: Pharma Marketing News - January 28, 2009 Category: Pharmaceuticals Source Type: info

The Future of DTC AdvertisingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A bad economy, anemic drug pipelines, and draconian regulations -- is a perfect storm brewing? We poll readers and experts to help predict the immediate future of DTC advertising and to get some insights. (Source: Pharma Marketing News)
Source: Pharma Marketing News - January 28, 2009 Category: Pharmaceuticals Source Type: info

Reforming the FDA: It All Starts with a New Commissioner!Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes the results of a recent survey in which varioous stakeholders voted for their choice. (Source: Pharma Marketing News)
Source: Pharma Marketing News - December 18, 2008 Category: Pharmaceuticals Source Type: info

Prepare or Die!Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Usually, at this time of the year, editors look back on the major stories of the past year. Let’s be different and look forward to the New Year! Not that it’s going to be any more pleasant than the old year; it’s just better to prepare for what’s coming than to reminisce about what’s come and gone. (Source: Pharma Marketing News)
Source: Pharma Marketing News - December 18, 2008 Category: Pharmaceuticals Source Type: info

Critical: What Daschle Plans to Do About the Healthcare CrisisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article summarizes the main points Daschle makes and reveals his plan for 'fixing' the problem. (Source: Pharma Marketing News)
Source: Pharma Marketing News - December 18, 2008 Category: Pharmaceuticals Source Type: info

Patient Assistance Program RankingsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In a syndicated study that identifies what physicians perceive to be the top pharmaceutical PAPs in the industry, Market Strategies -- a research and strategic consulting firm -- identified how PAP image influences overall corporate image among oncology physician specialists, what performance measures drive a pharmaceutical company's PAP image, and which companies are perceived as having the best PAP. (Source: Pharma Marketing News)
Source: Pharma Marketing News - December 18, 2008 Category: Pharmaceuticals Source Type: info

The Changing Policy LandscapeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The two traditional means by which pharmaceutical marketers have relied on for many, many years to encourage the uptake of new pharmaceutical products -- direct-to-consumer (DTC) advertising and physician marketing -- are about to change. Prepare now for the coming FDA and pharmaceutical marketing reforms. (Source: Pharma Marketing News)
Source: Pharma Marketing News - December 18, 2008 Category: Pharmaceuticals Source Type: info

Measuring & Communicating eSuccess: Strategy First, YouTube Later... MaybeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article is a review of a presentation by Aaron Uydess, Senior eMarketing Manager at Novo Nordisk, made at Eye for Pharma's 3rd eCommunication and Online Marketing Summit held October 23-24, 2008, in Boston, Massachusetts. Uydess presents a best-in-class approach to developing online plans that align with strategy, reduce silos, and measure and merchandise digital strategies across a pharmaceutical marketing organization. (Source: Pharma Marketing News)
Source: Pharma Marketing News - November 20, 2008 Category: Pharmaceuticals Source Type: info

Optimizing Market Access: A Guide to Effective Pricing, Reimbursement and Messaging StrategiesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In today's competitive market, pricing and reimbursement strategies are key to maximizing brand success and ROI. Because every country's healthcare system is different-and every product situation is unique-every brand requires a specific access plan, tailored to each market. And you must support each plan with effective messaging that ensures strong product acceptance and uptake. Experts from TNS Healthcare spoke on this issue in a recent webinar and during an exclusive interview with Pharma Marketing News. (Source: Pharma Marketing News)
Source: Pharma Marketing News - November 20, 2008 Category: Pharmaceuticals Source Type: info

Free Drug Samples: The Sales Rep's Last Great Hope?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Should free drug samples be banned? The new PhRMA Code on Interactions with Healthcare Professionals bans free pens and out-of-office lunches, but it doesn't ban samples. Many sales consider free drug samples an important marketing tactic that they can employ to gain access to physicians. In 2005, the pharmaceutical industry distributed more than $18 billion worth of drug samples. But critics are concerned that drug samples increase costs, raise questions about the appropriateness of treatment choices, and create real or perceived conflicts of interest in the medical profession. (Source: Pharma Marketing News)
Source: Pharma Marketing News - November 20, 2008 Category: Pharmaceuticals Source Type: info

Time for a New & Improved FDA CommissionerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
There is no doubt that Dr. Andrew von Eschenbach, the current FDA Commissioner, will soon be leaving the FDA and will not allow the door to hit him on the ass on the way out. Who will Obama nominate to replace von Eschenbach? There are plenty of special interest groups that would like to influence his decision. I wonder how Obama will balance all these diverse interests to pick the right person? Whoever the nominee is, the new FDA Commissioner will also need to balance competing interests (Source: Pharma Marketing News)
Source: Pharma Marketing News - November 20, 2008 Category: Pharmaceuticals Source Type: info